PROSPECTUS

CALCULATION OF REGISTRATION FEE

Title of Each Class of Securities Offered

Maximum Aggregate Offering Price

Amount of Registration Fee

Senior Unsecured Notes

$400,000,000.00

$12,280.00

PROSPECTUS

Dated March 29, 2006

Pricing Supplement Number: 4669

Filed Pursuant to Rule 424(b)(3)

PROSPECTUS SUPPLEMENT

Dated March 29, 2006

Dated September 27, 2007

Registration Statement: No. 333-132807

GENERAL ELECTRIC CAPITAL CORPORATION

GLOBAL MEDIUM-TERM NOTES, SERIES A

(Senior Unsecured Fixed Rate Notes)

Issuer:

General Electric Capital Corporation

Ratings:

Aaa/AAA

Trade Date:

September 27, 2007

Settlement Date (Original Issue Date):

October 2, 2007

Maturity Date:

September 20, 2013

Interest Rate:

5.400 %

Principal Amount:

US$400,000,000.00

Price to Public (Issue Price):

100.013 %

Agents Commission:

0.175%

All-in Price:

99.838 %

Net Proceeds to Issuer:

$399,352,000 (plus accrued interest from and including September 20, 2007 to but excluding October 2, 2007)

Accrued Interest:

$720,000

Benchmark:

4.125% US Treasury Note due August 31, 2012

Spread to Benchmark:

Plus 1.15%

Interest Payment Dates:

Semi-Annually on March 20th and September 20th, commencing March 20, 2008 and ending on the Maturity Date.

Day Count Convention:

30/360

Denominations:

Minimum of $1,000 with increments of $1,000 thereafter

Call Dates (if any):

N/A

Call Notice Period:

N/A

Put Dates (if any):

N/A

Put Notice Period:

N/A

CUSIP:

36962G3F9

Investing in the Notes involves risks. See "Risk of Foreign Currency Notes and Indexed Notes" on page 2 of the accompanying prospectus supplement and "Risk Factors" on page 2 of the accompanying prospectus.

 

Page 2

Dated September 27, 2007

Filed Pursuant to Rule 424(b)(3)

Registration Statement No. 333-132807

Plan of Distribution:

The Notes are being purchased by the underwriters listed below (the "Underwriters"), as principal, at 100.013% of the aggregate principal amount less an underwriting discount equal to 0.175% of the principal amount of the Notes.

Institutions

Commitment

Citigroup Global Markets Inc

$380,000,000

Credit Suisse Securities (USA) LLC

$20,000,000

Total

$400,000,000

The Company has agreed to indemnify the Underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as amended.

Additional Terms:

Reopening of Issue

The Notes are intended to be fully fungible and be consolidated and form a single issue for all purposes with the Issuers issues of US$500,000,000 and US$100,000,000 principal amount of Fixed Rate Notes due September 20, 2013 as described in the Issuers Pricing Supplement number 4656 dated September 13, 2007 and the Issuers Pricing Supplement number 4658 dated September 17, 2007, respectively.

Additional Information:

General

At June 30, 2007, the Company had outstanding indebtedness totaling $461.381 billion, consisting of notes payable within one year, senior notes payable after one year and subordinated notes payable after one year. The total amount of outstanding indebtedness at June 30, 2007, excluding subordinated notes payable after one year, was equal to $456.421 billion.

Consolidated Ratio of Earnings to Fixed Charges

The information contained in the Prospectus under the caption "Consolidated Ratio of Earnings to Fixed Charges" is hereby amended in its entirety, as follows:

Year Ended December 31,

Six Months Ended

2002

2003

2004

2005

2006

June 30, 2007

1.43

1.77

1.87

1.70

1.64

1.44

For purposes of computing the consolidated ratio of earnings to fixed charges, earnings consist of net earnings adjusted for the provision for income taxes, minority interest and fixed charges.

Fixed charges consist of interest and discount on all indebtedness and one-third of rentals, which the Company believes is a reasonable approximation of the interest factor of such rentals.

 

 

Page 3

Dated September 27, 2007

Filed Pursuant to Rule 424(b)(3)

Registration Statement No. 333-132807

 

 

CAPITALIZED TERMS USED HEREIN WHICH ARE DEFINED IN THE PROSPECTUS SUPPLEMENT SHALL HAVE THE MEANINGS ASSIGNED TO THEM IN THE PROSPECTUS SUPPLEMENT.